Stock analysts at BTIG Research started coverage on shares of Alpha Teknova (NASDAQ:TKNO) in a research report issued on Tuesday, Price Targets.com reports. The firm set a “buy” rating and a $26.00 price target on the stock. BTIG Research’s target price would suggest a potential upside of 46.40% from the company’s previous close.
Separately, Cowen assumed coverage on shares of Alpha Teknova in a research note on Tuesday. They issued an “outperform” rating for the company.
NASDAQ:TKNO opened at $17.76 on Tuesday. Alpha Teknova has a 52-week low of $16.90 and a 52-week high of $30.89.
Alpha Teknova, Inc provides reagents for bioprocessing, bioproduction, and molecular diagnostics. The company's reagents enable the discovery, research, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. It offers liquid culture, dry culture, agar, and animal-free media, as well as pre-poured plates, biological buffers, solutions, chemicals, and various treated and certified waters.
Recommended Story: Diversification
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.